Key Points
- Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare on Jan. 15 at $22.48, reducing her stake to 1,027,015 shares valued at about $23.09 million (a 2.84% ownership decrease).
- Those sales are part of a larger wave of disposals since Dec. 12 — Maroney has sold roughly 770,000 shares for approximately $15.4 million in total proceeds.
- Alignment Healthcare trades around $22.50 with a 50-day/200-day SMA of $19.21/$16.82 and a $4.5B market cap; analysts hold a consensus rating of "Moderate Buy" with a $21.86 average target and some firms (Piper Sandler) as high as $30, after recent revenue growth and a slight EPS beat despite negative margins.
Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) President Dawn Christine Maroney sold 30,000 shares of the company's stock in a transaction dated Thursday, January 15th. The shares were sold at an average price of $22.48, for a total transaction of $674,400.00. Following the completion of the transaction, the president owned 1,027,015 shares in the company, valued at $23,087,297.20. This trade represents a 2.84% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.
Dawn Christine Maroney also recently made the following trade(s):
- On Tuesday, January 6th, Dawn Christine Maroney sold 228,152 shares of Alignment Healthcare stock. The stock was sold at an average price of $21.33, for a total transaction of $4,866,482.16.
- On Friday, January 2nd, Dawn Christine Maroney sold 100,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $20.03, for a total transaction of $2,003,000.00.
- On Monday, December 29th, Dawn Christine Maroney sold 282,070 shares of Alignment Healthcare stock. The stock was sold at an average price of $18.74, for a total transaction of $5,285,991.80.
- On Monday, December 15th, Dawn Christine Maroney sold 113,319 shares of Alignment Healthcare stock. The shares were sold at an average price of $20.01, for a total transaction of $2,267,513.19.
- On Friday, December 12th, Dawn Christine Maroney sold 16,681 shares of Alignment Healthcare stock. The shares were sold at an average price of $20.02, for a total value of $333,953.62.
Alignment Healthcare Stock Performance
Shares of NASDAQ:ALHC opened at $22.50 on Friday. The business's 50 day simple moving average is $19.21 and its 200 day simple moving average is $16.82. Alignment Healthcare, Inc. has a 1 year low of $11.63 and a 1 year high of $23.19. The company has a debt-to-equity ratio of 1.99, a current ratio of 1.61 and a quick ratio of 1.61. The company has a market capitalization of $4.50 billion, a P/E ratio of -187.50, a P/E/G ratio of 5.92 and a beta of 1.16.
Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last released its earnings results on Thursday, October 30th. The company reported $0.02 earnings per share for the quarter, beating analysts' consensus estimates of ($0.01) by $0.03. The firm had revenue of $993.70 million during the quarter, compared to the consensus estimate of $980.90 million. Alignment Healthcare had a negative return on equity of 16.23% and a negative net margin of 0.57%.The company's revenue was up 43.5% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.14) EPS. On average, research analysts anticipate that Alignment Healthcare, Inc. will post -0.69 EPS for the current fiscal year.
Hedge Funds Weigh In On Alignment Healthcare
A number of institutional investors have recently added to or reduced their stakes in ALHC. Strs Ohio acquired a new position in shares of Alignment Healthcare in the first quarter worth approximately $600,000. Inspire Investing LLC bought a new position in Alignment Healthcare during the 3rd quarter worth approximately $1,129,000. Ameritas Investment Partners Inc. raised its holdings in Alignment Healthcare by 32.9% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 13,031 shares of the company's stock worth $182,000 after purchasing an additional 3,225 shares during the last quarter. Schroder Investment Management Group lifted its position in shares of Alignment Healthcare by 28.7% in the 2nd quarter. Schroder Investment Management Group now owns 248,163 shares of the company's stock worth $3,437,000 after purchasing an additional 55,314 shares during the period. Finally, Jump Financial LLC boosted its stake in shares of Alignment Healthcare by 173.8% in the 2nd quarter. Jump Financial LLC now owns 1,056,600 shares of the company's stock valued at $14,792,000 after purchasing an additional 670,750 shares during the last quarter. 86.19% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Several equities analysts have commented on the stock. Wall Street Zen lowered shares of Alignment Healthcare from a "buy" rating to a "hold" rating in a report on Saturday. Piper Sandler increased their price target on shares of Alignment Healthcare from $20.00 to $30.00 and gave the stock an "overweight" rating in a research report on Tuesday, January 6th. KeyCorp reissued an "overweight" rating on shares of Alignment Healthcare in a research note on Monday, November 24th. Cowen restated a "buy" rating on shares of Alignment Healthcare in a research note on Friday. Finally, The Goldman Sachs Group reaffirmed a "buy" rating and issued a $22.00 target price on shares of Alignment Healthcare in a report on Monday, November 3rd. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $21.86.
Check Out Our Latest Stock Report on Alignment Healthcare
Alignment Healthcare Company Profile
(
Get Free Report)
Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.
At the core of Alignment Healthcare's approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
